Clinical Trial Update: Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pemetrexed and gemcitabine in advanced head and neck cancer; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Head and Neck Cancer | Phase 2 | Status: TERMINATED | Results posted: 2022-08-05